ImmuCell Corporation, founded in 1982, is an animal health biologics company focused on developing, manufacturing, and commercializing products to improve the survivability and health of neonatal dairy and beef calves. Its primary product line, First Defense, uses hyperimmunized bovine colostrum to deliver pathogen-specific antibodies against E. coli, bovine coronavirus, and bovine rotavirus, preventing neonatal calf scours. Products are sold under brand names Dual-Force and Tri-Shield, and the company also offers a California Mastitis Test diagnostic.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001437749-26-010339 | EDGAR | 39K words |
| 2025-03-28 | 2024-12-31 | 0001013762-25-004072 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001213900-24-028718 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001213900-23-024080 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001213900-22-016147 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001213900-21-018473 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001213900-20-007650 | EDGAR | — |
| 2019-03-22 | 2018-12-31 | 0001213900-19-004653 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001213900-18-003621 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001213900-17-003009 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001437749-25-034817 | EDGAR | 45K words |
| 2025-08-14 | 2025-06-30 | 0001213900-25-076635 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001213900-25-043287 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001213900-24-097450 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001213900-24-068245 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001213900-24-042925 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001213900-23-086092 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001213900-23-065595 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001213900-23-038529 | EDGAR | — |
| 2022-11-21 | 2022-09-30 | 0001213900-22-074215 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001213900-22-046861 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001213900-22-025936 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-18 | 0001437749-26-008842 | EDGAR | 1K words |
| 2026-03-04 | 0001437749-26-006912 | EDGAR | — |
| 2026-02-09 | 0001437749-26-003514 | EDGAR | — |
| 2026-02-02 | 0001437749-26-002685 | EDGAR | — |
| 2026-01-08 | 0001437749-26-000885 | EDGAR | — |
| 2025-12-29 | 0001437749-25-038773 | EDGAR | — |
| 2025-11-13 | 0001437749-25-034819 | EDGAR | — |
| 2025-11-04 | 0001437749-25-033017 | EDGAR | — |
| 2025-10-07 | 0001437749-25-030631 | EDGAR | — |
| 2025-09-30 | 0001437749-25-030110 | EDGAR | — |
418 total filings indexed. 386 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000811641 |
| Ticker | ICCC |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Website | https://www.immucell.com |
| Listed | 1987-07-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report